Alfonso
Garcia De Coca

Foto de Alfonso

Foto de Hospital Clinic Barcelona

Hospital Clinic Barcelona

Barcelona, España

Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (6)

2024

Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma
Blood, Vol. 143, Núm. 7, pp. 597-603

2021

Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience
Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 6, pp. 413-420

2011

Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma
Leukemia, Vol. 25, Núm. 4, pp. 697-706

2009

The Presence of Normal PC at Diagnosis by Flow Cytometry is a Favorable Prognostic Feature in MM
CLINICAL LYMPHOMA & MYELOMA
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients
Blood, Vol. 114, Núm. 20, pp. 4369-4372

2008

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
Blood, Vol. 112, Núm. 10, pp. 4017-4023